Glucocorticoids in systemic sclerosis: patients’ beliefs and treatment adherence

References

• Jacobs JW, Bijlsma JW. Glucocorticoids in rheumatology: indications and routes of administration. Clin Exp Rheumatol 2011;29:S81–4.
   PubMed Web of Science ®Google Scholar
• Fardet L, Flahault A, Kettaneh A, Tiev KP, Genereau T, Toledano C, et al. Corticosteroid-induced clinical adverse events: frequency, risk factors and patient’s opinion. Br J Dermatol 2007;157:142–8.
   PubMed Web of Science ®Google Scholar
• Da Silva JA, Jacobs JW, Kirwan JR, Boers M, Saag KG, Ines LB, et al. Safety of low dose glucocorticoid treatment in rheumatoid arthritis: published evidence and prospective trial data. Ann Rheum Dis 2006;65:285–93.
   PubMed Web of Science ®Google Scholar
• Iudici M, van der Goes MC, Valentini G, Bijlsma JW. Glucocorticoids in systemic sclerosis: weighing the benefits and risks – a systematic review. Clin Exp Rheumatol 2013;31:157–65.
   PubMed Web of Science ®Google Scholar
• Steen VD. Scleroderma renal crisis. Rheum Dis Clin North Am 2003;29:315–33.
   PubMed Web of Science ®Google Scholar
• Iudici M, Fasano S, Iacono D, Russo B, Cuomo G, Valentini G. Prevalence and factors associated with glucocorticoids (GC) use in systemic sclerosis (SSc): a systematic review and meta-analysis of cohort studies and registries. Clin Rheumatol 2014;33:153–64.
   PubMed Web of Science ®Google Scholar
• Denton CP, Black CM. Scleroderma – clinical and pathological advances. Best Pract Res Clin Rheumatol 2004;18:271–90.
   PubMed Web of Science ®Google Scholar
• Pope JE, Ouimet JM, Krizova A. Scleroderma treatment differs between experts and general rheumatologists. Arthritis Rheum 2006;55:138–45.
   PubMed Web of Science ®Google Scholar
• Keirns CC, Goold SD. Patient-centered care and preference-sensitive decision making. J Am Med Assoc 2009;302:1805–6.
   Google Scholar
• Montori VM, Brito JP, Murad MH. The optimal practice of evidence-based medicine: incorporating patient preferences in practice guidelines. J Am Med Assoc 2013;310:2503–4.
   PubMed Web of Science ®Google Scholar
• Quill TE, Holloway RG. Evidence, preferences, recommendations – finding the right balance in patient care. N Engl J Med 2012;366:1653–5.
   PubMed Web of Science ®Google Scholar
• Barry MJ, Edgman-Levitan S. Shared decision making – pinnacle of patient-centered care. N Engl J Med 2012;366:780–1.
   PubMed Web of Science ®Google Scholar
• Horne R, Weinman J. Patients’ beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness. J Psychosom Res 1999;47:555–67.
   PubMed Web of Science ®Google Scholar
• Nestoriuc Y, Orav EJ, Liang MH, Horne R, Barsky AJ. Prediction of nonspecific side effects in rheumatoid arthritis patients by beliefs about medicines. Arthritis Care Res (Hoboken) 2010;62:791–9.
   PubMed Web of Science ®Google Scholar
• van den Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A, et al. 2013 Classification criteria for systemic sclerosis: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Ann Rheum Dis 2013;72:1747–55.
   Google Scholar
• Walker UA, Tyndall A, Czirjak L, Denton C, Farge-Bancel D, Kowal-Bielecka O, et al. Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials And Research group database. Ann Rheum Dis 2007;66:754–63.
   PubMed Web of Science ®Google Scholar
• LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA Jr, et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 1988;15:202–5.
   PubMed Web of Science ®Google Scholar
• Valentini G, Cuomo G, Abignano G, Petrillo A, Vettori S, Capasso A, et al. Early systemic sclerosis: assessment of clinical and pre-clinical organ involvement in patients with different disease features. Rheumatology (Oxford) 2011;50:317–23.
   Google Scholar
• Valentini G, D’Angelo S, Della Rossa A, Bencivelli W, Bombardieri S. European Scleroderma Study Group to define disease activity criteria for systemic sclerosis. IV. Assessment of skin thickening by modified Rodnan skin score. Ann Rheum Dis 2003;62:904–5.
   PubMed Web of Science ®Google Scholar
• Valentini G, Della Rossa A, Bombardieri S, Bencivelli W, Silman AJ, D’Angelo S, et al. European multicentre study to define disease activity criteria for systemic sclerosis. II. Identification of disease activity variables and development of preliminary activity indexes. Ann Rheum Dis 2001;60:592–8.
   PubMed Web of Science ®Google Scholar
• Argentero P, Torchio E, Tibaldi G, Horne R, Clatworthy J, Munizza C. The beliefs about drug treatment. The Italian version of the BMQ (the Beliefs about Medicines Questionnaire): its validity and applicability [in Italian]. Epidemiol Psichiatr Soc 2010;19:86–92.
   PubMedGoogle Scholar
• Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care 1986;24:67–74.
   PubMed Web of Science ®Google Scholar
• Apolone G, Mosconi P. The Italian SF-36 Health Survey: translation, validation and norming. J Clin Epidemiol 1998;51:1025–36.
   PubMed Web of Science ®Google Scholar
• La Montagna G, Cuomo G, Chiarolanza I, Ruocco L, Valentini G. [HAQ-DI Italian version in systemic sclerosis], in Italian. Reumatismo 2006;58:112–15.
   Google Scholar
• Tibaldi G, Clatworthy J, Torchio E, Argentero P, Munizza C, Horne R. The utility of the Necessity-Concerns Framework in explaining treatment non-adherence in four chronic illness groups in Italy. Chronic Illn 2009;5:129–33.
   PubMedGoogle Scholar
• Neame R, Hammond A. Beliefs about medications: a questionnaire survey of people with rheumatoid arthritis. Rheumatology (Oxford) 2005;44:762–7.
   PubMed Web of Science ®Google Scholar
• Butler JA, Peveler RC, Roderick P, Smith PW, Horne R, Mason JC. Modifiable risk factors for non-adherence to immunosuppressants in renal transplant recipients: a cross-sectional study. Nephrol Dial Transplant 2004;19:3144–9.
   PubMed Web of Science ®Google Scholar
• Horne R, Buick D, Fisher M, Leake H, Cooper V, Weinman J. Doubts about necessity and concerns about adverse effects: identifying the types of beliefs that are associated with non-adherence to HAART. Int J STD AIDS 2004; 15:38–44.
   PubMed Web of Science ®Google Scholar
• Menckeberg TT, Bouvy ML, Bracke M, Kaptein AA, Leufkens HG, Raaijmakers JA, et al. Beliefs about medicines predict refill adherence to inhaled corticosteroids. J Psychosom Res 2008;64:47–54.
   PubMed Web of Science ®Google Scholar
• Morrison E, Crosbie D, Capell HA. Attitude of rheumatoid arthritis patients to treatment with oral corticosteroids. Rheumatology (Oxford) 2003;42:1247–50.
   PubMed Web of Science ®Google Scholar
• Zerah L, Arena C, Morin AS, Blanchon T, Cabane J, Fardet L. [Patients’ beliefs about long-term glucocorticoid therapy and their association to treatment adherence], in French. Rev Med Interne 2012;33:300–4.
   Google Scholar
• van der Goes MC, Jacobs JW, Boers M, Andrews T, Blom-Bakkers MA, Buttgereit F, et al. Patient and rheumatologist perspectives on glucocorticoids: an exercise to improve the implementation of the European League Against Rheumatism (EULAR) recommendations on the management of systemic glucocorticoid therapy in rheumatic diseases. Ann Rheum Dis 2010;69:1015–21.
   PubMed Web of Science ®Google Scholar
• Goekoop-Ruiterman YP, de Vries-Bouwstra JK, Allaart CF, Kerstens PJ, Grillet BA, de Jager MH, et al. Patient preferences for treatment: report from a randomised comparison of treatment strategies in early rheumatoid arthritis (BeSt trial). Ann Rheum Dis 2007;66:1227–32.
   PubMed Web of Science ®Google Scholar
• van Tuyl LH, Plass AM, Lems WF, Voskuyl AE, Kerstens PJ, Dijkmans BA, et al. Discordant perspectives of rheumatologists and patients on COBRA combination therapy in rheumatoid arthritis. Rheumatology (Oxford) 2008; 47:1571–6.
   PubMed Web of Science ®Google Scholar
• Lin WS, Yang WS, Lin HY. Prednisolone non-compliance and its related factors in patients with systemic lupus erythematosus. Zhonghua Yi Xue Za Zhi (Taipei) 1995;56:244–51.
   Google Scholar
• Duru N, van der Goes MC, Jacobs JW, Andrews T, Boers M, Buttgereit F, et al. EULAR evidence-based and consensus-based recommendations on the management of medium to high-dose glucocorticoid therapy in rheumatic diseases. Ann Rheum Dis 2013;72:1905–13.
   PubMed Web of Science ®Google Scholar
• Marcum ZA, Sevick MA, Handler SM. Medication nonadherence: a diagnosable and treatable medical condition. J Am Med Assoc 2013;309:2105–6.
   PubMed Web of Science ®Google Scholar
• Hugtenburg JG, Timmers L, Elders PJ, Vervloet M, van Dijk L. Definitions, variants, and causes of nonadherence with medication: a challenge for tailored interventions. Patient Prefer Adherence 2013;7:675–82.
   PubMed Web of Science ®Google Scholar
• Dragomir A, Cote R, Roy L, Blais L, Lalonde L, Berard A, et al. Impact of adherence to antihypertensive agents on clinical outcomes and hospitalization costs. Med Care 2010;48:418–25.
   PubMed Web of Science ®Google Scholar
• Halpern R, Becker L, Iqbal SU, Kazis LE, Macarios D, Badamgarav E. The association of adherence to osteoporosis therapies with fracture, all-cause medical costs, and all-cause hospitalizations: a retrospective claims analysis of female health plan enrollees with osteoporosis. J Manag Care Pharm 2011;17:25–39.
   PubMed Web of Science ®Google Scholar
• DiMatteo MR. Variations in patients’ adherence to medical recommendations: a quantitative review of 50 years of research. Med Care 2004;42:200–9.
   PubMed Web of Science ®Google Scholar
• Arena C, Morin AS, Blanchon T, Hanslik T, Cabane J, Dupuy A, et al. Impact of glucocorticoid-induced adverse events on adherence in patients receiving long-term systemic glucocorticoid therapy. Br J Dermatol 2010;163:832–7.
   Google Scholar
• Koneru S, Shishov M, Ware A, Farhey Y, Mongey AB, Graham TB, et al. Effectively measuring adherence to medications for systemic lupus erythematosus in a clinical setting. Arthritis Rheum 2007;57:1000–6.
   PubMed Web of Science ®Google Scholar
• Horne R. Concordance, adherence and compliance in medicine taking. London: National Coordinating Centre for the Service Delivery and Organisation (NCCSDO), 2006.
   Google Scholar